LS Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,275
| Closed | -$654K | – | 796 |
|
|
2021
Q1 | $654K | Sell |
4,275
-897
| -17% | -$139K | 0.04% | 315 |
|
|
2020
Q4 | $808K | Sell |
5,172
-533
| -9% | -$68.5K | 0.04% | 305 |
|
|
2020
Q3 | $653K | Sell |
5,705
-38
| -0.7% | -$4.1K | 0.04% | 318 |
|
|
2020
Q2 | $645K | Sell |
5,743
-254
| -4% | -$27K | 0.04% | 312 |
|
|
2020
Q1 | $538K | Sell |
5,997
-984
| -14% | -$96.6K | 0.04% | 310 |
|
|
2019
Q4 | $755K | Sell |
6,981
-75
| -1% | -$8.02K | 0.04% | 367 |
|
|
2019
Q3 | $691K | Buy |
7,056
+349
| +5% | +$39.3K | 0.04% | 363 |
|
|
2019
Q2 | $878K | Buy |
6,707
+18
| +0.3% | +$2.32K | 0.05% | 305 |
|
|
2019
Q1 | $904K | Buy |
6,689
+94
| +1% | +$11.7K | 0.06% | 290 |
|
|
2018
Q4 | $642K | Sell |
6,595
-66
| -1% | -$7.8K | 0.04% | 340 |
|
|
2018
Q3 | $926K | Sell |
6,661
-17
| -0.3% | -$2.13K | 0.05% | 308 |
|
|
2018
Q2 | $829K | Buy |
6,678
+151
| +2% | +$17.6K | 0.05% | 326 |
|
|
2018
Q1 | $727K | Sell |
6,527
-249
| -4% | -$29.8K | 0.04% | 366 |
|
|
2017
Q4 | $810K | Buy |
6,776
+418
| +7% | +$50.9K | 0.05% | 335 |
|
|
2017
Q3 | $892K | Sell |
6,358
-175
| -3% | -$23.8K | 0.05% | 301 |
|
|
2017
Q2 | $795K | Buy |
6,533
+402
| +7% | +$46.8K | 0.05% | 325 |
|
|
2017
Q1 | $743K | Buy |
6,131
+706
| +13% | +$91K | 0.05% | 320 |
|
|
2016
Q4 | $664K | Buy |
5,425
+179
| +3% | +$21.9K | 0.05% | 326 |
|
|
2016
Q3 | $643K | Sell |
5,246
-349
| -6% | -$44.9K | 0.05% | 323 |
|
|
2016
Q2 | $653K | Sell |
5,595
-21
| -0.4% | -$2.98K | 0.05% | 335 |
|
|
2016
Q1 | $782K | Buy |
5,616
+359
| +7% | +$52.7K | 0.06% | 267 |
|
|
2015
Q4 | $1M | Buy |
5,257
+89
| +2% | +$15.5K | 0.08% | 228 |
|
|
2015
Q3 | $808K | Buy |
5,168
+100
| +2% | +$18.2K | 0.07% | 248 |
|
|
2015
Q2 | $916K | Buy |
5,068
+190
| +4% | +$32.8K | 0.07% | 234 |
|
|
2015
Q1 | $845K | Buy |
4,878
+21
| +0.4% | +$3.8K | 0.06% | 252 |
|
|
2014
Q4 | $899K | Sell |
4,857
-546
| -10% | -$101K | 0.07% | 223 |
|
|
2014
Q3 | $896K | Sell |
5,403
-86
| -2% | -$14.1K | 0.08% | 211 |
|
|
2014
Q2 | $858K | Buy |
5,489
+3
| +0.1% | +$474 | 0.07% | 214 |
|
|
2014
Q1 | $835K | Buy |
5,486
+2,644
| +93% | +$420K | 0.07% | 220 |
|
|
2013
Q4 | $378K | Buy |
2,842
+1,905
| +203% | +$229K | 0.03% | 268 |
|
|
2013
Q3 | $109K | Buy |
937
+263
| +39% | +$28.9K | 0.01% | 282 |
|
|
2013
Q2 | $62K | Buy |
+674
| New | +$65K | 0.01% | 293 |
|
Other funds holding ALXN
FCM
HI
DKCM
PCM
UOC